Monaghan D T, Cotman C W
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7532-6. doi: 10.1073/pnas.83.19.7532.
The excitatory amino acid receptors selectively activated by N-methyl-D-aspartate (N-Me-D-Asp) (also known as NMDA) are a major determinant of central nervous system neuronal excitability. We report here that rat brain synaptic plasma membranes contain a distinct population of L-[3H]glutamate binding sites with pharmacological properties indicative of the N-Me-D-Asp receptor. The N-Me-D-Asp sites are readily distinguished from other L-[3H]glutamate binding and uptake sites by their sharp pH optimum, more rapid association rate, preferential localization in synaptic structures, and lack of dependence on temperature and inorganic ions. As with other receptor systems, ligand binding at the N-Me-D-Asp site is reduced by guanine nucleotides but not by adenosine nucleotides. Binding is insensitive to ketamine and cyclazocine, indicating that sigma opiates inhibit N-Me-D-Asp excitation at a site different from that of the N-Me-D-Asp binding site. The quantitative pharmacological properties of N-Me-D-Asp-sensitive L-[3H]glutamate binding sites determined in a well-defined dendritic field (stratum radiatum of CA1) by quantitative autoradiography closely correlate to those of both the electrophysiologically identified N-Me-D-Asp receptors in the same dendritic field and the N-Me-D-Asp sites studied in membrane preparations. Under conditions that selectively reveal N-Me-D-Asp receptors, these sites are found to exhibit considerable anatomical specificity as evidenced by variations within cortical, striatal, and thalamic regions. Autoradiography also showed that regions in rodent and primate brain that are especially sensitive to anoxic and excitotoxic neuronal damage (e.g., Sommer's sector or CA1) have a high level of N-Me-D-Asp sites. Since N-Me-D-Asp receptors are known to contribute to these causes of neuronal loss, their selective distribution partially accounts for the pattern of selective damage seen in these pathological conditions.
由N - 甲基 - D - 天冬氨酸(N - Me - D - Asp,也称为NMDA)选择性激活的兴奋性氨基酸受体是中枢神经系统神经元兴奋性的主要决定因素。我们在此报告,大鼠脑突触质膜含有一群独特的L - [3H]谷氨酸结合位点,其药理学特性表明为N - Me - D - Asp受体。N - Me - D - Asp位点很容易与其他L - [3H]谷氨酸结合和摄取位点区分开来,其特点是具有尖锐的pH最佳值、更快的结合速率、在突触结构中的优先定位以及对温度和无机离子的不依赖性。与其他受体系统一样,鸟嘌呤核苷酸可降低N - Me - D - Asp位点的配体结合,但腺苷核苷酸则无此作用。结合对氯胺酮和环唑辛不敏感,这表明σ阿片类药物在与N - Me - D - Asp结合位点不同的位点抑制N - Me - D - Asp兴奋。通过定量放射自显影在明确的树突区域(CA1的放射层)中测定的对N - Me - D - Asp敏感的L - [3H]谷氨酸结合位点的定量药理学特性,与同一树突区域中电生理学鉴定的N - Me - D - Asp受体以及在膜制剂中研究的N - Me - D - Asp位点密切相关。在选择性揭示N - Me - D - Asp受体的条件下,发现这些位点表现出相当大的解剖学特异性,这在皮质、纹状体和丘脑区域的变化中得到了证明。放射自显影还显示,啮齿动物和灵长类动物脑中对缺氧和兴奋性毒性神经元损伤特别敏感的区域(例如,索默氏扇形区或CA1)具有高水平的N - Me - D - Asp位点。由于已知N - Me - D - Asp受体促成这些神经元丢失的原因,它们的选择性分布部分解释了在这些病理状况中所见的选择性损伤模式。